Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Amygdalin promotes the activity of T cells to suppress the progression of HBV-related hepatocellular carcinoma via the JAK2/STAT3 signaling pathway

Fig. 2

Effect of amygdalin on T cell activation and the phosphorylation of STAT3 and JAK2 in T cells. a, b The mean fluorescence intensity (MFI) of CD4+ and CD8+ T cells in total CD3+ T cells with or without amygdalin treatment determine by Flow cytometry analysis. n = 3. c, d The average mean fluorescence intensity (MFI) of p-STAT3 in CD4+ and CD8+ NC-T and HBV-T cells with or without amygdalin treatment determine by Flow cytometry analysis, n = 3. e The mRNA levels of STAT3 and JAK2 in NC-T and HBV-T cells with or without amygdalin treatment determined by real-time PCR, n = 3. f The protein levels of p-STAT3, STAT3, p-JAK2, and JAK2 in NC-T and HBV-T cells with or without amygdalin treatment determine by Immunoblotting, n = 3. *p < 0.05, **p < 0.01, ***p < 0.001, compared to NC-T group, #p < 0.05, ##p < 0.01, compared to HBV-T group

Back to article page